论文部分内容阅读
随着分子生物学的迅猛发展,在以单克隆抗体检测和 CT 及核磁共振为代表占领疾病诊断时,PCR(聚合酶链锁反应)则以崭新的面貌和惊人的速度渗透于临床医学领域。构成了新一代的诊断方法,深受国内外临床医学界的关注和欢迎。PCR技术是1985年由美国 PE—Cetus 公司研制成功并获世界专利的高新技术。五年后的今天,已有三种型号于临床医学人员见面。其型号是 TC—1/480/9600,它能够快速而可靠地在生物体外对任何特定目标 DNA(如病毒、细
With the rapid development of molecular biology, PCR (polymerase chain reaction) is infiltrated into the field of clinical medicine with a brand-new appearance and an astonishing speed when it comes to the diagnosis of diseases represented by monoclonal antibody detection and CT and nuclear magnetic resonance. Constitute a new generation of diagnostic methods, by the domestic and international clinical medical attention and welcome. PCR technology was developed in 1985 by the United States PE-Cetus company and won the world’s high-tech patents. Five years later, three models have been met by clinicians. Its model number is TC-1/480/9600, which can quickly and reliably in vitro for any specific target DNA (such as viruses, fine